247 related articles for article (PubMed ID: 24678746)
1. Povidone iodine in the treatment of adenoviral conjunctivitis in infants.
Özen Tunay Z; Ozdemir O; Petricli IS
Cutan Ocul Toxicol; 2015 Mar; 34(1):12-5. PubMed ID: 24678746
[TBL] [Abstract][Full Text] [Related]
2. The effects of povidone iodine (pH 4.2) on patients with adenoviral conjunctivitis.
Yazar H; Yarbag A; Balci M; Teker B; Tanyeri P
J Pak Med Assoc; 2016 Aug; 66(8):968-70. PubMed ID: 27524529
[TBL] [Abstract][Full Text] [Related]
3. A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis.
Pelletier JS; Stewart K; Trattler W; Ritterband DC; Braverman S; Samson CM; Liang B; Capriotti JA
Adv Ther; 2009 Aug; 26(8):776-83. PubMed ID: 19756415
[TBL] [Abstract][Full Text] [Related]
4. Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis.
Clement C; Capriotti JA; Kumar M; Hobden JA; Foster TP; Bhattacharjee PS; Thompson HW; Mahmud R; Liang B; Hill JM
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):339-44. PubMed ID: 20702820
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial.
Pinto RD; Lira RP; Abe RY; Zacchia RS; Felix JP; Pereira AV; Arieta CE; de Castro RS; Bonon SH
Curr Eye Res; 2015 Sep; 40(9):870-7. PubMed ID: 25310347
[TBL] [Abstract][Full Text] [Related]
6. Success of Masking 5% Povidone-Iodine Treatment: The Reducing Adenoviral Patient Infected Days Study.
Whiteside MM; Shorter ES; Margolis MS; Alvi F; Huecker JB; Than TP; Migneco MK; Harthan JS; Morettin CE; Hartwick ATE; Johnson SD; Perera CD; Gordon MO
Optom Vis Sci; 2021 May; 98(5):469-475. PubMed ID: 33973917
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children.
Isenberg SJ; Apt L; Valenton M; Del Signore M; Cubillan L; Labrador MA; Chan P; Berman NG
Am J Ophthalmol; 2002 Nov; 134(5):681-8. PubMed ID: 12429243
[TBL] [Abstract][Full Text] [Related]
8. Treatment of adenoviral keratoconjunctivitis with a combination of povidone-iodine 1.0% and dexamethasone 0.1% drops: a clinical prospective controlled randomized study.
Kovalyuk N; Kaiserman I; Mimouni M; Cohen O; Levartovsky S; Sherbany H; Mandelboim M
Acta Ophthalmol; 2017 Dec; 95(8):e686-e692. PubMed ID: 28342227
[TBL] [Abstract][Full Text] [Related]
9. Iodine povidone. A new paradigm in the treatment of adenoviral conjunctivitis?
González-Martín-Moro J; Zarallo-Gallardo J
Arch Soc Esp Oftalmol (Engl Ed); 2019 Nov; 94(11):521-522. PubMed ID: 31500885
[No Abstract] [Full Text] [Related]
10. [Povidone-iodine for treatment of adenoviral conjunctivitis: an in vitro study].
Monnerat N; Bossart W; Thiel MA
Klin Monbl Augenheilkd; 2006 May; 223(5):349-52. PubMed ID: 16705502
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of povidone-iodine 1.0%, 5.0%, and 10.0% irrigation combined with topical levofloxacin 0.3% as preoperative prophylaxis in cataract surgery.
Li B; Nentwich MM; Hoffmann LE; Haritoglou C; Kook D; Kampik A; Sheng M; Miño de Kaspar H
J Cataract Refract Surg; 2013 Jul; 39(7):994-1001. PubMed ID: 23680628
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with povidone-iodine eye drops in patients with conjunctivitis and keratoconjunctivitis.
Schuhman G; Vidic B
J Hosp Infect; 1985 Mar; 6 Suppl A():173-5. PubMed ID: 2860164
[TBL] [Abstract][Full Text] [Related]
13. Preoperative topical moxifloxacin 0.5% and povidone-iodine 5.0% versus povidone-iodine 5.0% alone to reduce bacterial colonization in the conjunctival sac.
Halachmi-Eyal O; Lang Y; Keness Y; Miron D
J Cataract Refract Surg; 2009 Dec; 35(12):2109-14. PubMed ID: 19969216
[TBL] [Abstract][Full Text] [Related]
14. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis.
Pepose JS; Ahuja A; Liu W; Narvekar A; Haque R
Am J Ophthalmol; 2018 Oct; 194():7-15. PubMed ID: 29787732
[TBL] [Abstract][Full Text] [Related]
15. In Vitro efficacy of cyclosporine a and various antiseptics and antiviral drugs on adenovirus genotype 8, a common cause of epidemic keratoconjunctivitis.
Aydamirov AS; Harbiyeli II; Ozturk G; Yarkin F; Erdem E; Yagmur M
Int Ophthalmol; 2023 May; 43(5):1701-1710. PubMed ID: 36346478
[TBL] [Abstract][Full Text] [Related]
16. The effect of povidone iodine flush versus drops on conjunctival colonization before intravitreal injections.
Safar A; Dellimore MC
Int Ophthalmol; 2007 Oct; 27(5):307-12. PubMed ID: 17440685
[TBL] [Abstract][Full Text] [Related]
17. The effect of povidone-iodine 2% eye drops in the treatment of adenoviral keratoconjunctivitis.
Soleimani M; Tabatabaei SA; Mirzaei A; Esfandiari A; Soleymanzadeh M; Sadeghi R; Rad AH
Oman J Ophthalmol; 2023; 16(1):69-74. PubMed ID: 37007229
[TBL] [Abstract][Full Text] [Related]
18. Safety and tolerability of a one-time, in-office administration of 5% povidone-iodine in the treatment of adenoviral conjunctivitis: The Reducing Adenoviral Patient Infected Days (RAPID) study.
Shorter E; Whiteside M; Harthan J; Margolis MS; Hartwick AT; Johnson S; Migneco M; Morettin C; Olson CK; Huecker J; Than T; Gordon MO
Ocul Surf; 2019 Oct; 17(4):828-832. PubMed ID: 31401340
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of local ocular toxicity in candidate anti-adenoviral agents in vivo.
Inoue H; Sonoda KH; Ishikawa M; Kadonosono K; Uchio E
Ophthalmologica; 2009; 223(4):233-8. PubMed ID: 19262070
[TBL] [Abstract][Full Text] [Related]
20. The Treatment Models for Adenoviral Keratoconjunctivitis in the Childhood Population.
Bekmez S; Eris E
Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1627-1632. PubMed ID: 32643975
[No Abstract] [Full Text] [Related]
[Next] [New Search]
